At Vitaloop, we are working on giving you clean water everywhere. We make it whole again, removing substances and pollution left by our actions. In a rapidly changing world, Vitaloop will be insurance, proven access to the one thing no one can exist without – clean, fresh, and healthy water. Our go-to-market product is called VITALOOP ORIGIN and is a ground-breaking, patented, high-tech water cleaning bottle that can remove almost everything harmful, manufactured and caused by climate change. It's your own mobile water filtration station using the revolutionary nanomaterial Graphene. It runs by a powerful pump and a rechargeable battery that will clean 450 ml of water in 60 seconds. Vitaloop Origin provides true independence wherever and whenever. VITALOOP- Water restored.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Markedsavdeling til utleie- Kommunikasjons- /PR- byrå med høy ekspertise innenfor digital markedsføring. Vi leier ut våre tjenester og fungerer for mange av våre kunder som bedfriftens egen markedsavdeling. Vi er også inne som strategisk rådgiver i større bedrifter som mangler spisskompetanse på sosiale medier, PR/krisehåndtering, annonsering og digital synlighet. Innsikt er nøkkelen for å lykkes, og vi har derfor tilgang på de beste analyseverktøy, og skreddersyr digitale markedsstrategier. VI SER NÅ PÅ MULIGHETEN TIL Å UTVIKLE ET HELT NYTT SYSTEM SOM MARKEDET HAR STORT BEHOV FOR. VI ØNSKER I DEN FORBINDELSE KONTAKT MED INVESTORER. Våre tjenester inkluder idag: Sosiale medier - drift og strategi Foto og video( herunder Cinematics, timelaps, animasjon, drone etc) Web/ SEO Innholdsproduksjon og artikler Analyse Digital mediestrategi PR og kampanjeplanlegging Pressemeldinger inkl. utsendelse Rådgiving og koordinator på store prosjekter Design og utarbeidelse av annonser, magasiner og Power Point-presentasjoner. Vi bygger merkevarekunnskap og øker lojalitet gjennom korrekt kommunikasjon i de medier kunden befinner seg, og innenfor tidsrammen hvor kundene er lydhøre for budskap. Kort oppsummert - Vi skaper engasjement for din merkevare i digitale kanaler.

ICT is a Norwegian technology development company that holds patents designed to bring new opportunities to the cryogenic liquids storage and transportation sectors via unique containers. The design targets the market for both large- and small-scale cryogenic applications. ICT’s solution is modular and suited for onshore as well as maritime use. The development of hydrogen infrastructure is slow and holding back widespread adoption. Transportation of large volumes is one of the major challenges that IC Technologies is determined to solve. Another challenge is the storage of liquid hydrogen. Current storage solutions resemble enlarged thermos flasks, and the hydrogen inside gradually evaporates over time. Our vision is a decarbonized world with green hydrogen as a major energy carrier.

Bookd AS ble etablert i 2021 og jobber med å forenkle bookingprosesser i underholdningsbransjen. Vårt fokus er å tilby underholdning på en enkel og intuitiv måte til bedrifts- og privatarrangementer. Vi har utviklet en app (iOS) hvor man kan finne og booke underholdning på en enkel måte. Vi tilbyr artister, DJs, komikere, foredragsholdere, dansere, kokker og annen underholdning som passer til ulike typer arrangementer. I 2022 er målet å etablere seg i Norge før vi skal skalere videre til nye markeder.Vi har en stor profilbase, samt gode og etablerte partnerskap med flere av Norges største eventbyråer og bedrifter.

Inspired by the sharing economy we're disrupting an old-fashioned industry, saving institutions in the health care sector immense amounts of money and time.uWork is Norway's 1st platform for on-demand healthcare staffing. Launched in May 2016, uWork has already partnered up with more than 50 healthcare institutions in souther Norway, and we're expanding rapidly. Our talent pool of pre-screened healthcare specialists now consists of more than 150 uWorkers, with more signing up every single day.

Your recruitment partner. We empower tech teams by connecting them with the right talent. At Your Headway, we go beyond traditional hiring - we understand culture, vision, and growth potential. By bridging ambitious companies with exceptional talents, we help build teams that innovate, scale, and succeed long-term.

Salire AS is a Norwegian tech-startup that develops applications that help small and medium sizes businesses grow. Our product AIFlow is an innovative CRM solution tailored around hundreds of Norwegian businesses. We like to call it a boosted CRM because it offers an all in one experience with a simple interface, eliminating the need for many applications to run your business daily.

We help rental services get ready for the future The development is clear – We need to make better use of our resources. We need a more circular economy where products are reused by more people and have a longer lifetime. In this picture, renting and subscription of products and services plays an important role. Sharefox has developed a technology platform that enables new models for both startups and established businesses. We are a passionate and highly skilled team of about 12 persons in Oslo, and 10 developers working remotely. In March 2022 we secured 23 million NOK in funding, and will use this money to scale the company further, including going internationally. You can currently find us at Vollebekk Fabrikker in Oslo, but will move to an other place in Oslo in the autumn of 2022.

DoMore Diagnostics is on a mission to transform cancer diagnostics with artificial intelligence to improve patient care and make drug development more effective. We use state-of-the-art methods to improve patients’ quality of life and help clinicians make more informed decisions. Our technology is based on pioneering research on utilizing artificial intelligence to increase the prognostic value from routine clinical pathology cancer tissue samples. The extensive research conducted at top universities (University in Oslo, Oxford University and University College of London) has been published in leading and high impact scientific journals such as The Lancet and Nature Reviews Cancer. These new methods have resulted in fully automated histotyping that provide objective and precise prognostic information that correlate and out-perform existing markers. This novel histotyping can guide selection of therapy to avoid over- and undertreatment. It can also make cancer drug development more effective by ensuring more precise diagnosis and prognosis, which is the fundament for precision medicine. Artificial intelligence is set for a breakthrough in medicine and several megatrends are pushing for new solutions in cancer diagnostics. Digital pathology and new AI algorithms will play a significant role in the future of medicine and hold multiple commercial opportunities. DoMore Diagnostics is at the forefront of the field and will bring these next generation products to the clinic.

Parallelo er et teknologiselskap som hjelper arkitekter og utbyggere å designe bedre boliger – raskere. Boligbransjen er blant de minst digitaliserte næringene i verden. Hvert bygg tegnes fra grunnen av, og avgjørende beslutninger om leilighetsmiks, markedspotensial og bærekraft tas ofte uten reelle data. Parallelo endrer dette. Gjennom avanserte algoritmer genererer og optimaliserer Parallelo komplette leilighetsplaner på sekunder. Plattformen lar arkitekter og utviklere jobbe tettere sammen, utforske flere alternativer - og har dokumentert å gi prosjekter bedre arealutnyttelse, lavere CO₂-avtrykk og typisk 10 - 15 % høyere prosjektverdi. Vi jobber tett sammen med Coera, Nordens raskest voksende arkitektkontor, for å utvikle og teste løsninger i reelle prosjekter. Som utvikler i Parallelo får du jobbe side om side med arkitekter, designere og planleggere – med kort vei fra kode til faktisk verdi. I Parallelo tror vi på More Room to Play – en kultur med frihet, tillit og høyt tempo. Du får frihet til å utforske nye ideer, jobbe fra hvor du vil, og være med på å forme hvordan fremtidens boliger og byer blir til.

Clikk gives a home to all of your social media accounts and unites their content feeds. We are here to save you time, increase your visibility online and make sharing your social profiles easy and effortless. Discover new people, connect with them, and share your socials in one place! Let’s Clikk!

ShiftX is on a mission to help Close the Knowledge Gap in organizations by empowering people to share their knowledge and learn from one another. ShiftX is a SaaS that makes it easy to collaboratively visualize how a business operates, building a common shared understanding of the business. We are a passionate team that believes in the power of great products. We are looking for talented people to join us in building software for the future of work.

SammeVei is a tech startup that rolled out 2 mobility apps in the past 4 years: SammeVei; the leading ridesharing app in Norway for the sustainable urban commuting and Pick App; the revolutionary home delivery app for anything anytime! Our vision is backed by the star investors and innovation grant. We believe in on-demand mobility in urban transportation; both in the movement of people and goods.

VOED er en helt ny sosial videoredigeringsapp som forenkler videoredigering på mobil. Ved å kombinere enkle og intuitive redigeringsverktøy, et unikt musikkbibliotek og en delt kamerarull-løsning for raskere deling av klipp i grupper skal vi ta opp kampen med de etablerte sosiale mediene ved å revolusjonere hvordan videoer deles. VOED er i dag et team på fire kamerater som sitter hos StartupLab Bergen for å jobbe med prosjektet. Vår MVP lanseres om kort tid etter to års arbeid. Hittil har vi hentet støtte fra Innovasjon Norge og Universitetet i Stavanger, kommet til nasjonal finale i Venture Cup, vunnet GründerHub-stipendet på kr. 50 000,- og deltatt på en rekke akseleratorprogram. Vi søker nå en CTO og co-founder til å bli med på eventyret. Er dette deg? Sjekk ut stillingsutlysningen under!